BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho E, Ryu EJ, Jiang F, Jeon UB, Cho M, Kim CH, Kim M, Kim ND, Hwang TH. Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus. Drug Des Devel Ther 2018;12:2467-74. [PMID: 30122903 DOI: 10.2147/DDDT.S171269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Han SR, Lee CH, Im JY, Kim JH, Kim JH, Kim SJ, Cho YW, Kim E, Kim Y, Ryu JH, Ju MH, Jeong JS, Lee SW. Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation. Mol Ther Nucleic Acids 2021;23:154-68. [PMID: 33335800 DOI: 10.1016/j.omtn.2020.10.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Li L, Liu S, Han D, Tang B, Ma J. Delivery and Biosafety of Oncolytic Virotherapy. Front Oncol. 2020;10:475. [PMID: 32373515 DOI: 10.3389/fonc.2020.00475] [Cited by in Crossref: 18] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
3 Islam SMBU, Lee B, Jiang F, Kim EK, Ahn SC, Hwang TH. Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase. Cancers (Basel) 2020;12:E228. [PMID: 31963415 DOI: 10.3390/cancers12010228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
4 Cho E, Islam SMBU, Jiang F, Park JE, Lee B, Kim ND, Hwang TH. Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes. Cancer Res Treat 2020;52:309-19. [PMID: 31401821 DOI: 10.4143/crt.2019.161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]